Agfa-Gevaert N.V. (AGFB):企業の財務・戦略的SWOT分析

◆英語タイトル:Agfa-Gevaert N.V. (AGFB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4962
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:メディア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Agfa-Gevaert N.V. (AGFB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Agfa-Gevaert N.V. (Agfa) develops, manufactures and distributes analog and digital imaging systems and IT solutions for printing and healthcare industries. Its major solutions include integrated IT solutions; state-of-the-art diagnostic imaging and contrast media solutions for hospitals and other healthcare centers; digital printing solutions for sign and display and industrial printing; prepress solutions; classic films; functional foils; and advanced coatings and chemicals. The company has production facilities and research centers in Belgium, Canada, Germany, France, Italy, the US and China. Agfa is headquartered in Mortsel, Belgium.

Agfa-Gevaert N.V. Key Recent Developments

Aug 22,2018: Agfa-Gevaert publishes results for the second quarter of 2018
May 08,2018: Agfa-Gevaert publishes its first quarter 2018 results
Apr 10,2018: At AAOE 2018, Agfa and Hitachi Health care Americas will cover their full , joint imaging portfolio
Mar 07,2018: Agfa-Gevaert publishes its full year 2017 results regulated information
Feb 14,2018: Dirk De Man to become new CFO of Agfa-Gevaert

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Agfa-Gevaert N.V. – Key Facts 6
Agfa-Gevaert N.V. – Key Employees 7
Agfa-Gevaert N.V. – Key Employee Biographies 8
Agfa-Gevaert N.V. – Major Products and Services 9
Agfa-Gevaert N.V. – History 15
Agfa-Gevaert N.V. – Company Statement 22
Agfa-Gevaert N.V. – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Section 2 – Company Analysis 26
Company Overview 26
Agfa-Gevaert N.V. – Business Description 27
Business Segment: Afga Graphics Segment 27
Overview 27
Financials 27
Business Segment: Afga Healthcare Segment 27
Overview 27
Financials 28
Key Stats 28
Business Segment: Afga Specialty Products Segment 28
Overview 28
Financials 28
Agfa-Gevaert N.V. – Corporate Strategy 29
Agfa-Gevaert N.V. – SWOT Analysis 30
SWOT Analysis – Overview 30
Agfa-Gevaert N.V. – Strengths 30
Agfa-Gevaert N.V. – Weaknesses 31
Agfa-Gevaert N.V. – Opportunities 32
Agfa-Gevaert N.V. – Threats 33
Agfa-Gevaert N.V. – Key Competitors 34
Section 3 – Company Financial Ratios 35
Financial Ratios – Capital Market Ratios 35
Financial Ratios – Annual Ratios 36
Performance Chart 39
Financial Performance 39
Financial Ratios – Interim Ratios 40
Financial Ratios – Ratio Charts 41
Agfa-Gevaert N.V., Recent Deals Summary 42
Section 4 – Company’s Recent Developments 43
Aug 22, 2018: Agfa-Gevaert publishes results for the second quarter of 2018 43
May 08, 2018: Agfa-Gevaert publishes its first quarter 2018 results 46
Apr 10, 2018: At AAOE 2018, Agfa and Hitachi Health care Americas will cover their full , joint imaging portfolio 49
Mar 07, 2018: Agfa-Gevaert publishes its full year 2017 results regulated information 50
Feb 14, 2018: Dirk De Man to become new CFO of Agfa-Gevaert 54
Nov 08, 2017: Agfa-Gevaert publishes its third quarter 2017 results – regulated information 55
Aug 23, 2017: Agfa-Gevaert publishes its second quarter 2017 results – regulated information 58
May 09, 2017: Agfa-Gevaert publishes its first quarter 2017 results – regulated information 61
Apr 19, 2017: Agfa-Gevaert: Market introduction of Agfa’s UNIQOAT at PV SNEC 64
Section 5 – Appendix 65
Methodology 65
Ratio Definitions 65
About GlobalData 69
Contact Us 69
Disclaimer 69

List of Tables
Agfa-Gevaert N.V., Key Facts 6
Agfa-Gevaert N.V., Key Employees 7
Agfa-Gevaert N.V., Key Employee Biographies 8
Agfa-Gevaert N.V., Major Products and Services 9
Agfa-Gevaert N.V., History 15
Agfa-Gevaert N.V., Other Locations 23
Agfa-Gevaert N.V., Subsidiaries 23
Agfa-Gevaert N.V., Key Competitors 34
Agfa-Gevaert N.V., Ratios based on current share price 35
Agfa-Gevaert N.V., Annual Ratios 36
Agfa-Gevaert N.V., Annual Ratios (Cont...1) 37
Agfa-Gevaert N.V., Annual Ratios (Cont...2) 38
Agfa-Gevaert N.V., Interim Ratios 40
Agfa-Gevaert N.V., Recent Deals Summary 42
Currency Codes 65
Capital Market Ratios 65
Equity Ratios 66
Profitability Ratios 66
Cost Ratios 67
Liquidity Ratios 67
Leverage Ratios 68
Efficiency Ratios 68

List of Figures
Agfa-Gevaert N.V., Performance Chart (2013 - 2017) 39
Agfa-Gevaert N.V., Ratio Charts 41

★海外企業調査レポート[Agfa-Gevaert N.V. (AGFB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Polski Koncern Naftowy ORLEN SA:企業の戦略・SWOT・財務情報
    Polski Koncern Naftowy ORLEN SA - Strategy, SWOT and Corporate Finance Report Summary Polski Koncern Naftowy ORLEN SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Orkla ASA:企業のM&A・事業提携・投資動向
    Orkla ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Orkla ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cevec Pharmaceuticals GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Cevec Pharmaceuticals GmbH (Cevec) is a healthcare products company that offers production of biopharmaceuticals. The company produces recombinant glycoproteins and gene therapy vectors. It utilizes its CAP-Go technology developed expression system based on human cells, for the production of …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ishida Co., Ltd.:企業の戦略・SWOT・財務情報
    Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Canara Bank (CANBK):企業の財務・戦略的SWOT分析
    Canara Bank (CANBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CMS Energy Corp (CMS):企業の財務・戦略的SWOT分析
    CMS Energy Corp (CMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a pharmaceutical company. It is engaged in drug discovery and development of treatments for cancer.The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and acute myeloid le …
  • Unichem Laboratories Ltd (UNICHEMLAB):企業の財務・戦略的SWOT分析
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Power Finance Corp Ltd (PFC):企業の財務・戦略的SWOT分析
    Power Finance Corp Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nexans SA (NEX)-エネルギー分野:企業M&A・提携分析
    Summary Nexans S.A. (Nexans) is a provider of cables and cabling solutions. The company offers copper and fiber-optic cables and cabling systems. It serves network operators, equipment and infrastructure manufacturers, and builders, installers and distributors in submarine and land, oil and gas, min …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • Qu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Qu Biologics Inc (Qu Biologics) is a developer of immunotherapies designed to restore normal immune function. The company develops site specific immunomodulators that restore the body's innate immune system to treat immune-related diseases and cancer. Its site specific immunotherapy technolo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆